|
|
Executive Summary: Drug Delivery Markets, Vol. IV: TransdermalPublished by: Kalorama Information Executive Summaries Published: Apr. 1, 2007 - 6 Pages Table of ContentsPlease Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report. AbstractKalorama Information's Executive Summaries provide a comprehensive overview of the contents contained in our full-length market intelligence reports.Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market. The report from which this Executive Summary is compiled is Drug Delivery Series, Volume 4, Transdermal/Transmucosal Delivery, and the full study abstract is as follows: New biological treatments are being developed at a record place, but their potential could be compromised by significant obstacles to delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. New systems are being developed, and Kalorama's Drug Delivery Markets Series covers these new systems.
The fourth volume of this series, Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery is a complete overview of a delivery mechansim that offers some advantages: low pain, infection risk, fewer side effects and polonged delivery over time. |
|
|||
|
About MarketResearch.com
|
||||